Chromocell Therapeutics C... (CHRO)
2.68
-0.02 (-0.74%)
At close: Jan 23, 2025, 3:59 PM
2.86
6.70%
After-hours Jan 23, 2025, 07:38 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 |
| Revenue | n/a | n/a | n/a | 199.93K |
| Cost of Revenue | 2.58M | 391.73K | 209.05K | 138.59K |
| Gross Profit | -2.58M | -391.73K | -209.05K | 61.35K |
| Operating Income | -6.86M | -2.32M | -839.00K | -1.35M |
| Interest Income | n/a | n/a | n/a | n/a |
| Pretax Income | -7.38M | -2.46M | -595.39K | -660.58K |
| Net Income | -7.38M | -2.46M | -595.39K | -660.58K |
| Selling & General & Admin | 4.28M | 1.93M | 629.95K | 1.42M |
| Research & Development | 2.58M | 391.73K | 209.05K | 138.59K |
| Other Expenses | n/a | n/a | n/a | n/a |
| Operating Expenses | 6.86M | 2.32M | 839.00K | 1.55M |
| Interest Expense | 518.51K | 140.43K | 253.00 | 1.68K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
| Cost & Expenses | 6.86M | 2.32M | 839.00K | 1.55M |
| Income Tax | n/a | -690.45K | -839.00K | -1.35M |
| Shares Outstanding (Basic) | 5.77M | 5.77M | 5.77M | 5.77M |
| Shares Outstanding (Diluted) | 5.77M | 5.77M | 5.77M | 5.77M |
| EPS (Basic) | -1.28 | -0.43 | -0.1 | -0.11 |
| EPS (Diluted) | -1.28 | -0.43 | -0.1 | -0.11 |
| EBITDA | -6.86M | -1.63M | n/a | n/a |
| Depreciation & Amortization | n/a | 690.45K | 839.00K | 1.35M |